1055102

Abbvie Biotechnology Ltd. — FEI 3004620772

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 1, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Barceloneta, PR (United States)